PTP inhibitor immunotherapy (Kanyr Pharma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePTP inhibitor immunotherapy (Kanyr Pharma)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKanyr Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKanyr Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A